ACIU NASDAQ
AC Immune S.A.
1W: +8.3%
1M: -3.9%
3M: +8.8%
YTD: -18.8%
1Y: -10.2%
3Y: -9.0%
5Y: -60.5%
$2.73
-0.09 (-3.02%)
Weekly Expected Move ±7.3%
$2
$3
$3
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$154M
-33.1% ▼
5Y CAGR: -8.3%
Total Liabilities
$109M
-7.7% ▼
5Y CAGR: +36.3%
Shareholders Equity
$45M
-60.0% ▼
5Y CAGR: -26.9%
Cash & Investments
$92M
-44.7% ▼
5Y CAGR: -16.5%
Total Debt
$5M
-16.2% ▼
5Y CAGR: +15.4%
Net Debt
-$22M
+27.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $82M | $32M | $78M | $36M | $27M |
| Short-Term Investments | $116M | $91M | $25M | $129M | $65M |
| Cash & ST Investments | $198M | $123M | $103M | $165M | $92M |
| Net Receivables | $975K | $408K | $15M | $1M | $682K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $428K | $392K | $622K | $1M | $0 |
| Total Current Assets | $203M | $128M | $125M | $172M | $97M |
| Property, Plant & Equip. | $8M | $7M | $7M | $8M | $7M |
| Goodwill & Intangibles | $50M | $50M | $50M | $50M | $50M |
| Long-Term Investments | $0 | $0 | $361K | $0 | $585K |
| Other Non-Current Assets | $363K | $361K | $0 | $415K | $0 |
| Total Non-Current Assets | $59M | $58M | $58M | $59M | $58M |
| Total Assets | $261M | $186M | $183M | $231M | $154M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $929K | $2M | $3M | $2M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $853K |
| Deferred Revenue | $0 | $0 | $138K | $0 | $84M |
| Other Current Liabilities | $717K | $587K | $0 | $85M | $4M |
| Total Current Liabilities | $20M | $11M | $14M | $101M | $95M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $7M | $3M | $6M | $13M | $9M |
| Total Non-Current Liabilities | $9M | $5M | $9M | $18M | $15M |
| Total Liabilities | $29M | $17M | $22M | $119M | $109M |
| — Equity — | |||||
| Common Stock | $2M | $2M | $2M | $2M | $2M |
| Retained Earnings | -$201M | -$264M | -$316M | -$368M | -$440M |
| Accumulated OCI | $0 | $10K | -$51K | -$5K | $7K |
| Total Stockholders Equity | $232M | $169M | $161M | $112M | $45M |
| Total Liabilities & Equity | $261M | $186M | $183M | $231M | $154M |
| — Key Metrics — | |||||
| Total Debt | $3M | $3M | $3M | $5M | $5M |
| Net Debt | -$79M | -$29M | -$75M | -$31M | -$22M |
| Total Investments | $116M | $91M | $25M | $129M | $65M |